The incidence of withholding and withdrawal of therapy in the setting of multi-organ failure in critically ill patients has increased. Epidemiological data on the decision-making process of withholding or withdrawal of therapy from Australian and New Zealand intensive care units is sparse. We examined the clinical and electronic records of 179 consecutive patients, admitted to the ICU between 1st January 2000 and 31st December 2001, who had acute renal injury. Acute renal replacement therapy was offered in 11.2% of patients. Therapy was withheld or withdrawn in 21.2% of patients. The levels of supportive care were comparable between those who had therapy withheld or withdrawn and those who had full intensive care therapy until such a decision was made. Predicted mortality (OR 1.04, 95%CI: 1.01-1.08, P=0.03) and age (OR 1.04, 95%CI: 1.00-1.08, P=0.03) were independently associated with the decision to withhold or withdraw therapy. The mean ICU stay of those with withdrawal or withholding of therapy was much shorter than those with full therapy (2.5 vs 5.7 days). This was likely to be due to an older age of our cohort, rapid progressive nature of the acute disease, a different clinical approach to treating critically ill elderly patients, or a combination of these factors. This pattern of practice was quite different from those reported from ICUs in other parts of the world. A prospective multi-centre observational study will clarify the pattern of practice in this important area of intensive care practice in Australasia.
Acute renal failure in the setting of multi-organ failure in critically ill patients is associated with a high mortality 1 . While there is some evidence that aggressive renal replacement therapy may improve clinical outcomes in such patients 2 , there is still no consensus on how to define acute renal failure or when to start acute renal replacement therapy [3] [4] [5] . Apart from considering the clinical risks and benefits of acute renal replacement therapy, psychological and ethical issues are also known to be important when clinicians are asked about starting and continuing acute renal replacement therapy 6 . However, there was hardly any degree of consistency in the decision-making process in a recent survey on intensivists' opinion in this area 7 .
The incidence of withholding and withdrawal of therapy in the setting of multi-organ failure in critically ill patients has increased 8, 9 . Apart from acknowledging the patient's wishes and the patient's perception of his or her quality of life, severity of the acute disease has also been reported to be important in a clinician's decision-making process 10 . However, epidemiological data on the decision-making process of withholding or withdrawal of therapy from Australian and New Zealand intensive care units (ICU) is sparse.
The aim of this study was to investigate the incidence of withholding or withdrawal of therapy, and pathophysiological factors that were associated with such a decision in a cohort of patients with acute renal injury.
METHODS
This was a retrospective cohort study. The data was based on the same data set of another epidemiological dialysis study carried out in the unit 11 . After obtaining approval from the hospital ethics committee, two independent investigators retrieved and examined the electronic and clinical records of 899 ICU admissions between 1st January 2000 and 31st December 2001. The study period of this cohort was chosen because the renal replacement therapy service was only started in this ICU after this period. The North Shore Hospital in Auckland provides secondary hospital services for a population of 400,000. There are no neurosurgical or cardiothoracic surgery services in the hospital. The ICU is a six-bed multidisciplinary general intensive care unit, admitting general surgical, general medical, orthopaedic, and obstetric patients. The average length of stay in ICU was 59.3 hours and the average APACHE II score was 19.1 during the study period. This hospital has the least available ventilated ICU beds per population (0.9 ventilated beds per 100,000) in Australia and New Zealand 12 .
In this cohort study, acute renal injury or impairment was defined as a serum creatinine level of greater than 0.12mmol/l and urea level greater than 8 mmol/l when the usual creatinine level was less than 0.12 mmol/l. The clinical history and the computerized laboratory results in the 12 months before and after ICU admission determined the usual renal function. Patients with pre-existing renal impairment were also included if there was a significant increase (>0.06 mmol/l) in serum creatinine level during their stay in the ICU. These definitions are similar to those suggested by Bellomo, Kellum and Ronco 13 . Patients with serum creatinine level less than 0.12 mmol/l during their stay in ICU but with raised creatinine level before or after their ICU stay were excluded. Apart from patients' co-morbidity and their demographic data, we also recorded the supportive care that the patient required during their ICU stay. The decision to withhold or withdraw therapy in ICU was noted. If the patient had been treated in another hospital in the Greater Auckland area during their ICU stay, the relevant clinical record was also retrieved. The decision to withdraw or limit therapy in this ICU is made in conjunction with the patient's wishes and the family's opinions. The quality of life of the patient before the acute illness, the perceived future quality of life after the acute illness, and the reversibility of the acute illness were discussed with the patient and/or the family before the decision to withdraw or limit therapy was made. It is difficult to differentiate between withholding and withdrawal of therapy, and it has been argued that there is no difference ethically between withholding and withdrawal of therapy 14 . In this ICU, withholding of therapy such as invasive mechanical ventilation or dialysis is usually recommended when the patient has limited pre-morbid quality of life, with significant comorbidity or a combination of both. On the other hand, withdrawal of therapy is more likely to happen when the pre-existing treatment is regarded as prolonging an inevitable imminent death and when the chance of recovery is extremely minimal. In this study, either withholding or withdrawal of therapy was classified as the same outcome of interest. When more than one ICU consultant and attending nurse is involved in the care of the patient, a consensus decision is reached between the ICU consultants and the nurses before the patient and/or the family is approached to discuss limitation of therapy. Treatment will be continued if there is no consensus between the patient, the family, and the medical and nursing staff.
Using univariate analyses, potential clinical risk factors were tested for association with occurrence of the decision of withholding and withdrawal of therapy. Analysis of variance (ANOVA) was used for all continuous variables (if they were normally distributed) and Chi-square test or Mann-Whitney test was used for categorical variables (also for continuous variables if they had different variances between the two groups or when the data was not normally distributed). All significant variables from univariate analyses were further analysed by multiple logistic regression analysis.
In this study, a P value less than 0.10 was regarded as significant in the univariate analyses and <0.05 was regarded as significant in the multivariate analyses, and all tests were two-tailed tests unless stated otherwise. Statistical analyses were done by SPSS for windows statistical software (version 9.0, 1998 SPSS Inc. IL, U.S.A.) and confidence intervals were calculated by Confidence Interval Analysis (version 2.0.0 BMJ 2000) if they were not generated by SPSS software.
RESULTS
The cohort consisted of 179 critically ill adult patients, with an average age of 66 and average APACHE II score of 23.4. The mean APACHE II score of this cohort was higher than the mean APACHE II score (19.1) of all ICU admissions (n=899) during the studied period. Apart from having acute renal dysfunction, a significant propor-tion also required inotropic support (76.5%) and mechanical ventilation (60.3%). The decision to withhold or withdraw therapy was made in 21.2% of the cohort. Sepsis was the primary diagnosis or leading diagnosis in 80% of the cohort. No patient in this cohort study had disseminated malignancy or cerebrovascular disease. The detailed characteristics of the cohort are described in Table 1 .
Withholding or withdrawal of therapy was associated with older age, mechanical ventilation, higher FiO 2 requirement, shorter ICU stay, absence of renal replacement therapy, and higher APACHE II score and predicted mortality ( Table 2 ). Pre-existing individual medical diseases such as ischaemic heart disease, heart failure, diabetes mellitus, and chronic renal impairment were not significantly associated with the decision to withhold or withdraw therapy.
Because ICU length of stay was a dependent variable of the decision to limit therapy, it was not entered into the logistic regression analysis. Only two out of six variables remained significant in the final logistic regression model. They were age (OR= 1.04, 95% CI: 1.00-1.08, P=0.03), and the predicted mortality (OR=1.04, 95% CI: 1.01-1.09, P=0.03) ( Table 3) .
DISCUSSION
When resources are limited, clinicians may limit or withdraw intensive care therapy such as acute renal replacement therapy in patients who are sickest and who suffer from conditions that are considered least likely to be reversible 10, 15 . While APACHE II score or APACHE II score derived predicted mortality has never been used as a clinical guide to facilitate clinical decision making, our study has confirmed that the predicted mortality and the age of patient are important factors that are associated with the decision to withhold or withdraw therapy. Pre-existing medical diseases such as ischaemic heart disease, heart failure, diabetes mellitus, and chronic renal impairment were not significantly associated with the 511 WITHHOLDING AND WITHDRAWAL OF THERAPY decision to withhold or withdraw therapy. Clinicians often make intuitive judgements about likely survival when withholding or withdrawal of therapy is considered. These judgements seem to relate to a combination of factors such as age of the patient, diagnosis of the acute illness, severe pre-existing diseases, and the acute pathophysiological derangement as reflected by the APACHE II score derived predicted mortality. Similar findings were also observed in other observational studies [15] [16] [17] .
In this study, the levels of supportive care were similar between those who had limitation of therapy and those who had no such limitation, until the point of making such a decision. However, we found that those patients who had limitation of therapy had a much shorter ICU stay than those who had full intensive care therapy (mean ICU stay of 2.5 vs 5.7 days). This pattern was quite different from the results of similar studies in Canada 16 , Israel 17 , South Africa and England 18 where mean ICU stay was usually more than 6 to 9 days before the decision to withhold or withdraw therapy was considered. We believe this difference was due to an older age of our cohort, rapid progressive nature of the acute disease, a different clinical approach to treat elderly patients who are critically ill and very likely to die regardless of therapy 19 , or a combination of these factors.
In this study, not all patients who had withholding or withdrawal of therapy died at the end of their ICU stay although all died within days in the same hospitalization. These patients were discharged to the wards to have general supportive care and/or palliative care once the decision to limit and withdraw therapy was made. Previously published data also showed similar results, with no meaningful hospital survival rate in patients with limitation of therapy after ICU discharge 9, 18, 20 . Discharging critically ill patients to ward or home to die once the decision to limit therapy is made may improve access of the family to the dying patient and add more dignity to the dying process 20 . How frequent this practice is and whether it is related to ICU resource issues remains unknown. Our study showed that patients with limitation of therapy had a higher actual mortality than the predicted mortality. Similar findings were also observed when patients were triaged "not for ICU admission" in another study 21 . Quality of life, long-term survival, and patients' wishes were, however, important issues for our patients that are not represented by these numerical data. Data on prediction of these outcomes are unfortunately sparse.
There were a few limitations with this study. Because this was a retrospective observational study, we could not identify some of the factors that might have affected the clinicians' decision. These include the patients' precise pre-morbid quality of life, patients and their families' religious and cultural beliefs and the ICU bed availability at the time of the decision-making. The study was also limited to those with acute renal injury and we cannot extrapolate the results to patients without acute renal injury. Finally, because this was a single-centre study, we could not generalize our findings as a general pattern for all intensive care units in Australia and New Zealand. A prospective multi-centre observational study will clarify the pattern of the practice in this important area of intensive care practice in Australasia.
In conclusion, we found that the decision to withhold or withdraw therapy in patients with acute renal injury was made earlier in our ICU than in some other ICUs in other parts of the world. This is likely to be due to a different clinical approach in treating critically ill elderly patients. While we do not rely on APACHE II score derived predicted mortality and patient's age to make such a decision, these two factors might have subconsciously affected the intensivists' decision making process. 
